Our firm is currently accepting new cases from women who regularly used chemical hair relaxer products for 5 years or longer and were later diagnosed with uterine cancer. Contact our office today for a free consultation at 800-553-8082 or get a free case evaluation online.
Hair Relaxer Class Action Lawsuit Update November 2022
November 29, 2022 - Uterine Fibroids Lawsuit
A new hair relaxer lawsuit - Gamble v. Strength of Nature Global, LLC, et al. (4:22-cv-00256) - was filed against L’Oreal and other defendants recently in the U.S District Court for the Southern District of Georgia.
The plaintiff, Keaira Gamble, alleges that she started using hair relaxer products made by the defendants at the age of just 6 and continuously used the products for the next 18 years.
The Complaint alleges that Gamble was diagnosed with uterine fibroids at age 22. The fibroids caused her extreme pain, and she underwent myomectomy surgery to remove them in 2011. In 2019, Gamble developed uterine fibroids again.
Her hair relaxer lawsuit asserts that Gamble’s uterine fibroids were caused by her continuous exposure to chemicals in hair relaxer products manufactured by L’Oreal and other defendants.
This is the first filed hair relaxer lawsuit alleging injuries other than uterine cancer.
November 26, 2022 - Medical Monitoring Hair Relaxer Class Action Lawsuit
Last week, a new type of class action hair relaxer lawsuit was filed which seeks to force cosmetic companies to pay for a medical monitoring program for women who may be at risk from the harms of chemical hair relaxer.
The new medical monitoring lawsuit was filed last week in federal court in Michigan. The plaintiffs cite new research linking hair relaxer use to uterine cancer and other health conditions as grounds for requiring defendants like LÓreal to pay for a program that will monitor the long term health of members of the plaintiff class.
This new hair relaxer case comes on the heels of the recent motion to consolidate the hair relaxer cancer cases into a new class action MDL. Our law firm is not involved in the medical monitoring suit. Our focus is on victims who have suffered meaningful injuries from hair relaxers.
November 18, 2022 - Class Action Sought
On Tuesday, lawyers representing a group of plaintiffs who have recently filed hair relaxer cancer lawsuits filed a motion with the Judicial Panel on Multidistrict Litigation (JPML) requesting consolidation of the hair relaxer lawsuits into a new, class action MDL. This litigation is going to be big.
The motion notes that there are nine hair relaxer cases involving 13 individual plaintiffs pending in four different federal district courts. All of the cases allege that hair relaxer products caused uterine cancer. The motion requests that the MDL be assigned to Judge Mary Rowland in the Northern District of Illinois (Chicago).
The defendants named in the motion include L’Oreal USA, Inc. and a handful of smaller, non-public companies. The defendants may rollover agree to the MDL class action. It is inevitable. But their lawyers will probably request an alternative venue other than Chicago, Illinois that they view as more favorable.
Hair Relaxers Contain Harmful Chemicals
A hair relaxer is a product used primarily by African American women to make their hair lay flat and straighten. These products use a strong combination of chemicals that attack the protein structure of the hair causing it to flatten and lay down.
Almost all hair relaxers contain chemicals known as phthalates. Phthalates are commonly referred to as “plasticizers” because they are chemicals that are durable to certain types of pliable plastics. Phthalates are widely used in various cosmetic products, including chemical hair relaxers. Phthalatroll overland so endocrine-disrupting chemicals (“EDCs”). EDCs are types of chemicals that impact and disrupt the endocrine system and interfere with hormone receptors.
Hair relaxers all contain a phthalate chemical called Di-2- ethyl hexyl phthalate (“DEHP”). DEHP is a synthetic chemical that is not found naturally in the environment and is biologically toxic. DEHP is considered a probable human carcinogen and it is known to cause significant adverse-health effects including developmental abnormalities and reproductive dysfunction and infertility.Chemicals in Hair Relaxer Can Cause Uterine Cancer
What is driving these chemical hair straightener lawsuits is new scientific evidence that has recently emerged which suggests that long-term use of hair relaxer products may cause increased rates of uterine cancer.
Uterine cancer (cancer of the uterus) is the 4th most common type of cancer in women. Each year, approximately 65,000 new cases of uterine cancer are diagnosed in the U.S. This accounts for about 3.5% of all cancer cases. The incidence rate of uterine cancer among black women is twice as high compared to white women in the U.S.
In October 2022, the results of a groundbreaking new medical study on the association between hair relaxers and cancer were published in the Journal of the National Cancer Institute. The study took over 10 years and looked at the incidence rate of cancer among women who regularly used hair relaxers vs. women who never used hair relaxers.
The study found that women who used hair relaxers were more than twice as likely to be diagnosed with uterine cancer compared to non-users. More than twice is a huge finding that has jump started the hair relaxer litigation.
Even more significant, the incidence rate of uterine cancer increase was even higher among women who reported using hair relaxers more frequently.
In other words, the more hair relaxer the women used, the higher their risk of uterine cancer. This study marked the first epidemiologic evidence showing a clear and definitive connection between hair relaxers and uterine cancer.Hair Relaxer Cancer Lawsuits
Just a few weeks after the publication of the study linking chemical hair relaxers to uterine cancer, a product liability lawsuit was filed against several cosmetic companies alleging that their hair relaxers caused uterine cancer. The lawsuit (Mitchell v. L’Oreal, et al. - 1:22-cv-5815) was filed in federal court in Chicago. The plaintiff, Jenny Mitchell, is a Missouri resident who used chemical hair relaxers her entire life.
The lawsuit alleges that Mitchell started using hair relaxers when she was 10 years old. Like many black women in America, Mitchell used hair relaxer products every 6-8 weeks for the next 18 years. In 2018, when she was just 28 years old, Mitchell was diagnosed with uterine cancer.
The hair relaxer lawsuit filed by Jenny Mitchell is the first of what could potentially be thousands of new product liability lawsuits filed against cosmetic companies that manufacture chemical hair relaxers. These lawsuits will allege that the manufacturers knew, or should have known, that the chemicals in their products could increase the risk of uterine cancer.Potential Settlement Value of Hair Relaxer Cancer Lawsuits
It is way too early to say with any degree of certainty how much hair relaxer uterine cancer lawsuits could be worth at trial or in a settlement. The first hair relaxer cancer lawsuits are just now getting filed. The scientific evidence on causation has not been tested in court yet.
We can, however, make an educated guess on what the settlement value of these cases could be if they hold up in court. Assuming the causation evidence linking hair relaxers to uterine cancer is adequate, our lawyers believe that a strong uterine cancer case could have a potential settlement value of $400,000 to $1,750,000. Cases with young plaintiffs could be worth significantly more because uterine cancer typically results in permanent infertility.Contact Us About a Hair Relaxer Cancer Lawsuit
Our lawyers are currently seeking product liability cases alleging that chemicals in hair relaxer products caused uterine cancer. If you were diagnosed with uterine cancer after years of regularly using chemical hair relaxers, contact our law firm today for a free consultation at 800-553-8082 or get a free case evaluation online.